1290056-64-2

Upstream product

• 103203-83-4 3-(allyloxy)benzoic acid 
• 79250-46-7 methyl 3-(prop-2-enyloxy)benzoate 
• 725228-49-9 tert-butyl 3-(piperidin-4-yl)benzylcarbamate 
• 1290056-61-9 tert-butyl 3-(1-(3-(allyloxy)benzoyl)piperidin-4-yl)benzylcarbamate 
• 1290056-62-0 tert-butyl 3-(1-(3-(2,3-dihydroxypropoxy)benzoyl)piperidin-4-yl)benzylcarbamate 
• 1290056-63-1 tert-butyl 3-(1-(3-(3-((tert-butyldimethylsilyl)oxy)-2-hydroxypropoxy)benzoyl)piperidin-4-yl)benzylcarbamate 
• 150255-96-2 (3‐cyanophenyl)boronic acid 
• 6952-59-6 3-cyanobromobenzene 
• 19099-93-5 benzyl 4-oxo-1-piperidinecarboxylate 
• 286961-24-8 benzyl 1,2,3,6-tetrahydro-4-(trifluoromethylsulphonyloxy)-pyridine-1-carboxylate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 19438-10-9 methyl 3-hydroxybenzoate 

Relevant academic research and scientific papers

COFERONS AND METHODS OF MAKING AND USING THEM

The present invention is directed to a monomer useful in preparing therapeutic compounds. The monomer includes one or more pharmacophores which potentially binds to a target molecule with a dissociation constant of less than 300 μM and a linker element connected to the pharmacophore. The linker element has a molecular weight less than 500 daltons, is connected, directly or indirectly through a connector, to the pharmacophore.